抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基丁基]-2-丙烯酰胺 | WP 1130 | 856243-80-6 | C19H18BrN3O |
|
2-醛基-4-甲氧基苯硼酸 | tariquidar | 206873-63-4 | C38H38N4O6 |
|
2-苯基乙炔磺酰胺 | pifithrin-μ | 64984-31-2 | C8H7NO2S |
|
2-羟基-4-[[2-[[(4-甲基苯基)磺酰基]氧基]乙酰基]氨基]苯甲酸 | S3I-201 | 501919-59-1 | C16H15NO7S |
|
2-羟基-3-[5-(吗啉-4-甲基)吡啶-2-基]-1H-吲哚-5-甲腈 | AZD1080 | 612487-72-6 | C19H18N4O2 |
|
2-硝基-5-(对甲苯磺酰基)呋喃 | 2-[(4-Methylphenyl)sulfonyl]-5-nitrofuran | 343351-67-7 | C11H9NO5S |
|
2-甲氧基雌二醇 | 2-Methoxyestradiol | 362-07-2 | C19H26O3 |
|
2-甲氧基丙酸甲酯 | methyl 2-methoxypropionate | 17639-76-8 | C5H10O3 |
|
2-甲氧基-N-[3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺 | CP-724714 | 537705-08-1 | C27H27N5O3 |
|
2-甲氧基-N-(3-甲基-2-氧代-1,2,3,4-四氢喹唑啉-6-基)苯磺酰胺 | PFI-1 | 1403764-72-6 | C16H17N3O4S |
|
2-甲基-8-羟基-4-喹唑啉酮 | 8-hydroxy-2-methyl-4(3H)-quinazolinone | 90417-38-2 | C9H8N2O2 |
|
2-甲基-6-(苯乙炔)吡啶盐酸盐 | 2-methyl-6-(phenylethynyl)pyridine | 96206-92-7 | C14H11N |
|
2-甲基-5-硝基苯磺酸[(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]甲基肼盐酸盐 | PI3Kalpha Inhibitor VIII | 372196-77-5 | C16H15BrClN5O4S |
|
2-甲基-5-[(4-甲基苯基)氨基]-1,3-苯并噻唑-4,7-二酮 | Ryuvidine | 265312-55-8 | C15H12N2O2S |
|
2-甲基-1-[[2-甲基-3-(三氟甲基)苯基]甲基]-6-(4-吗啉基)-1H-苯并咪唑-4-羧酸 | GSK2636771 | 1372540-25-4 | C22H22F3N3O3 |
|
2-甲基-1,4-苯撑双(4-(((4-(丙烯酰氧)丁氧基)羰基)氧)苯甲酸酯) | 2-methylbenzene-1,4-diyl bis[4-({[4-(acryloyloxy)butoxy]carbonyl}oxy)benzoate] | 187585-64-4 | C37H36O14 |
|
2-溴-4-(6,7-二甲氧基喹唑啉-4-基氨基)苯酚 | 4-(3-bromo-4-hydroxyphenyl)amino-6,7-dimethoxyquinazoline | 211555-04-3 | C16H14BrN3O3 |
|
2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺 | 2-Propenamide, 2-cyano-3-(5-(2,5-dichlorophenyl)-2-furanyl)-N-5-quinolinyl- | 304896-28-4 | C23H13Cl2N3O2 |
|
2-氯-N-[4-氯-3-(2-吡啶基)苯基]-4-(甲磺酰基)苯甲酰胺 | vismodegib | 879085-55-9 | C19H14Cl2N2O3S |
|
2-氯-N-(2-(4-(2-(吡咯烷-1-基)乙氧基)苯基氨基)嘧啶-5-基)-5-(3-(三氟甲基)苯酰胺)苯甲酰胺 | TG100948 | 1001341-27-0 | C31H28ClF3N6O3 |
|
2-氯-6-[(2R)-3-[[1,1-二甲基-2-(2-萘基)乙基]氨基]-2-羟基丙氧基]苯腈 | NPS 2143 | 284035-33-2 | C24H25ClN2O2 |
|
2-氯-5-硝基-N-苯基苯酰胺 | 2-chloro-5-nitrobenzanilide | 22978-25-2 | C13H9ClN2O3 |
|
2-氯-5-硝基-N-4-吡啶基苯甲酰胺 | T0070907 | 313516-66-4 | C12H8ClN3O3 |
|
2-氯-3-(4-甲基-1-哌嗪)喹噁啉 | 2-chloro-3-(4-methylpiperazin-1-yl)quinoxaline | 155584-74-0 | C13H15ClN4 |
|
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 | 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}acetamide | 742112-33-0 | C26H19F3N4O |
|
2-氨基-4-(4-氟萘-1-基)-6-异丙基嘧啶 | RS-127445 | 199864-87-4 | C17H16FN3 |
|
2-吗啉代-8-苯基色酮 | LY 294002 | 154447-36-6 | C19H17NO3 |
|
2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 | 2-(4-morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one | 587871-26-9 | C21H17NO3S2 |
|
2-叔丁基-6-甲基-4H-吡喃-4-酮 | 2-tert-butyl-6-methyl-4H-pyran-4-one | 225378-47-2 | C10H14O2 |
|
2-二甲基氨基乙基-2-甲基-二苯甲基醚柠檬酸盐 | orphenadrine citrate | 4682-36-4 | C6H8O7*C18H23NO |
|
2-乙基-3-甲基戊酰胺 | N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrobenzenesulfonamide | 852808-04-9 | C42H45ClN6O5S2 |
|
2-[[5-氯-2-[[2-甲氧基-4-(4-吗啉)苯基]氨基]-4-嘧啶]氨基]-N-甲基苯甲酰胺 | TAE226 | 761437-28-9 | C23H25ClN6O3 |
|
2-[[4-(5-乙基-4-嘧啶基)-1-哌嗪基]甲基]-6-(三氟甲基)-1H-苯并咪唑 | PF-4708671 | 1255517-76-0 | C19H21F3N6 |
|
2-[[3-溴-5-叔丁基-4-羟基苯基]亚甲基]丙二腈 | 2-(3-bromo-5-(tert-butyl)-4-hydroxybenzylidene)malononitrile | 65678-07-1 | C14H13BrN2O |
|
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 | XMD8-92 | 1234480-50-2 | C26H30N6O3 |
|
2-[[2-[[1-[(二甲基氨基)乙酰基]-5-(甲氧基)-2,3-二氢-1H-吲哚-6-基]氨基]-7H-吡咯并[2,3-D]嘧啶-4-基]氨基]-6-氟-N-甲基苯甲酰胺 | GSK1838705A | 1116235-97-2 | C27H29FN8O3 |
|
2-[[(2E)-3-(2-萘基)-1-氧代-2-丁烯基]氨基]苯甲酸 | BIBR1532 | 321674-73-1 | C21H17NO3 |
|
2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-噻唑-2-基)苯基]氨基]-5-嘧啶羧酰胺盐酸盐 | PRT062607 hydrochloride | 1370261-97-4 | C19H23N9O*ClH |
|
2-[[(1R)-1-[7-甲基-2-(4-吗啉基)-4-氧代-4H-吡啶并[1,2-a]嘧啶-9-基]乙基]氨基]苯甲酸 | AZD 6482 | 1173900-33-8 | C22H24N4O4 |
|
2-[4-(1,3-苯并二氧杂环戊烷-5-基)-2-(1,1-二甲基乙基)-1H-咪唑-5-基]-6-甲基-吡啶 | SB 505124 | 694433-59-5 | C20H21N3O2 |
|
2-[2-氟-4-[(2S)-2-吡咯烷基]苯基]-1H-苯并咪唑-7-甲酰胺 | A-966492 | 934162-61-5 | C18H17FN4O |
|
2-[2-(4-庚基苯基)乙基]-6-羟基苯甲酸 | MG149 | 1243583-85-8 | C22H28O3 |
|
2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基]-1-(4-吗啉基)乙酮 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)ethanone | 2854-32-2 | C23H23ClN2O4 |
|
2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | 2-(6-aminopurin-9-ylmethyl)-5-methyl-3-o-tolyl-3H-quinazolin-4-one | 371242-69-2 | C22H19N7O |
|
2-[(4-氨基-1H-吡唑并[3,4-D]嘧啶-1-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | PIK-293 | 1369877-00-8 | C22H19N7O |
|
2-[(3R)-3-甲基-4-吗啉基]-4-(1-甲基-1H-吡唑-5-基)-8-(1H-吡唑-3-基)-1,7-萘啶 | 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine | 1876467-74-1 | C20H21N7O |
|
2-[(3,5-二氟-4-羟基苯基)氨基]-7,8-二氢-5,7-二甲基-8-(3-甲基丁基)-6(5H)-蝶啶酮 | 2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one | 501437-28-1 | C19H23F2N5O2 |
|
2-[(3,4-二甲氧基苯甲酰基)氨基]-4,5,6,7-四氢-苯并[b]噻吩-3-甲酰胺 | TCS 359 | 301305-73-7 | C18H20N2O4S |
|
2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-7-甲酰胺 | veliparib | 912444-00-9 | C13H16N4O |
|
2-[(2-羟基萘-1-基亚甲基)氨基]-n-(1-苯乙基)苯甲酰胺 | sirtinol | 410536-97-9 | C26H22N2O2 |
|